Welcome to our dedicated page for Enhabit news (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit stock.
Enhabit, Inc. (NYSE: EHAB), operating as Enhabit Home Health & Hospice, is a national home health and hospice provider whose activities generate a steady flow of company news and disclosures. As a public company listed on the New York Stock Exchange, Enhabit regularly issues press releases and files Form 8-K reports covering its financial results, strategic updates, leadership developments, and participation in investor conferences.
News about Enhabit often centers on quarterly earnings announcements, where the company reports net service revenue, segment performance for Home Health and Hospice, Adjusted EBITDA, and other financial and operational metrics. These releases highlight trends in home health and hospice admissions, average daily census, patient days, and segment-level profitability, as well as updates on branch openings, de novo locations, and changes in cost per patient day.
Investors following EHAB news will also see regular updates on guidance for net service revenue, Adjusted EBITDA, and Adjusted EPS, along with explanations of non-GAAP financial measures and same-store comparisons. Enhabit’s communications discuss how unusual or nonrecurring items affect its results and how management evaluates core operating performance.
Another key category of Enhabit news involves corporate and governance developments. The company has announced a CEO transition plan, retention awards for senior officers, approval of its 2025 Equity and Incentive Compensation Plan, and voting results from its annual meeting. In addition, Enhabit frequently reports on its participation in healthcare and home care conferences hosted by major financial institutions, where its leadership teams take part in fireside chats and presentations.
For readers tracking EHAB, this news flow provides insight into Enhabit’s home health and hospice operations, financial performance, capital structure, and governance decisions. Monitoring these updates can help contextualize the company’s strategic focus on patient care in the home and its reported progress across its nationwide footprint.
Encompass Health and Enhabit have won a significant legal victory in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The court found that while employed at Encompass Health, these officers misappropriated acquisition opportunities, used confidential information, and recruited employees for a competing venture.
The Court awarded damages against private equity firms Vistria Group and Nautic Partners for aiding these breaches. The remedy includes a constructive trust entitling Encompass Health and Enhabit to 43% of VitalCaring Group's profits and future exit proceeds, approximately $1.62 million in mitigation damages, and attorneys' fees due to defendants' bad faith conduct including evidence tampering.
Enhabit (NYSE: EHAB), a leading home health and hospice provider, announced its participation in the BofA Securities 2024 Home Care Conference. President and CEO Barb Jacobsmeyer, incoming CFO Ryan Solomon, and SVP of Strategic Finance & Treasurer Jobie Williams will participate in a fireside chat on Tuesday, Dec. 10, at 9:00 a.m. EST. The event will be webcast live and available for replay on the company's investor website. Enhabit operates 256 home health locations and 112 hospice locations across 34 states, leveraging advanced technology for patient care delivery.
Enhabit Home Health & Hospice (NYSE: EHAB) has appointed Ryan Solomon as its new Chief Financial Officer, effective Dec. 9, 2024. Solomon brings over 20 years of corporate strategy and finance experience, including eight years as CFO in home health and hospice. He previously served as CFO at AccentCare and Aspirion, where he managed financial planning, accounting, tax, treasury, revenue cycle, and corporate development. Solomon will replace Crissy Carlisle, the current CFO, as part of a previously announced transition. His experience includes building finance teams, systems integration, mergers and acquisitions, and operational business planning.
Enhabit Inc (NYSE: EHAB) reported Q3 2024 financial results with net service revenue of $253.6 million, down 1.8% year-over-year. The company reported a net loss of $110.2 million and Adjusted EBITDA of $24.5 million, up 5.6%. Home health segment saw non-Medicare admissions increase 20.1%, while hospice segment revenue grew 11% with average daily census up 6.9%. Due to lower recertifications and hurricane impacts, Enhabit revised its full-year 2024 guidance, with net service revenue now expected between $1,031-$1,046 million and Adjusted EBITDA between $98-$102 million.
Enhabit Home Health & Hospice (NYSE: EHAB) has been recognized as an Age-Friendly Health Systems Participant by the Institute for Healthcare Improvement (IHI). This recognition acknowledges Enhabit's commitment to implementing the 4Ms of Age-Friendly Care: What Matters, Medication, Mentation, and Mobility.
Bud Langham, executive vice president of clinical excellence & strategy at Enhabit, emphasized the company's dedication to providing the best possible care for older adults. The Age-Friendly Health Systems initiative, supported by The John A. Hartford Foundation and other partners, aims to improve care for older adults across various healthcare settings, including home-based care.
By participating in this movement, Enhabit joins a select group of healthcare systems worldwide working to tailor care to patients' goals and preferences, aligning with their vision of excellence in elder care.
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, has announced its participation in two upcoming investor conferences. The company's President and CEO Barb Jacobsmeyer and CFO Crissy Carlisle will attend:
- Jefferies Healthcare Services "Back to School" Summit and Bus Tour on Aug. 28 in Nashville, Tenn.
- 2024 Wells Fargo Healthcare Conference on Sept. 5 in Boston, Mass., including investor meetings and a fireside chat.
The fireside chat will be webcast live at 11 a.m. EDT and available for replay on Enhabit's investor website. Enhabit operates 256 home health locations and 112 hospice locations across 34 states, focusing on expanding patient care possibilities in the home through advanced technology and compassionate teams.
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, has announced that CFO Crissy Carlisle will step down from her role. The company has initiated a comprehensive search for her successor. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities.
CEO Barb Jacobsmeyer praised Carlisle's contributions since Enhabit became a public company two years ago, highlighting her role in achieving business stability and positioning the organization for growth. Carlisle expressed pride in her accomplishments, including establishing a finance organization and enhancing the control environment.
Enhabit operates 256 home health locations and 112 hospice locations across 34 states. The company will hold a conference call to discuss its second quarter 2024 financial results.
Enhabit, Inc. (NYSE: EHAB) reported its Q2 2024 financial results, showing mixed performance across its home health and hospice segments. Key highlights include:
- Net service revenue of $260.6 million, down 0.6% year-over-year
- Net loss of $0.2 million, improved from a $74.4 million loss in Q2 2023
- Adjusted EBITDA of $25.2 million, up 5.4% year-over-year
- Earnings per share of $0.00, adjusted EPS of $0.07
The home health segment saw a 6.4% increase in total admissions, driven by a 25.2% growth in non-Medicare admissions. Hospice segment revenue grew 3.9%, with average daily census increasing 2.7% year-over-year. The company updated its full-year 2024 guidance, slightly lowering revenue expectations but maintaining its adjusted EBITDA forecast.
AREX Capital Management, LP, owning 4.9% of Enhabit, Inc. (NYSE: EHAB), announced the election of Mark W. Ohlendorf to Enhabit's board of directors at the 2024 Annual Meeting. AREX expressed satisfaction with this outcome, highlighting Ohlendorf's financial expertise as important for improving Enhabit's financial reporting and investor communications. The campaign emphasized Enhabit's poor performance in its first two years as a public company and proposed strategies for improvement. AREX stressed that this result should not be seen as approval of the status quo, noting significant stockholder support for change. Both leading proxy advisors recommended replacing three directors. AREX urged the board to focus on correcting Enhabit's undervaluation and improving stockholder outcomes.
Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, has announced preliminary results from its 2024 Annual Meeting of Stockholders. According to the initial vote count, eight of Enhabit's director nominees have been elected to the board, along with one nominee proposed by AREX Capital Management, LP. The elected directors will serve one-year terms expiring in 2025.
The preliminary results indicate that stockholders have chosen a mix of Enhabit's nominees and an external candidate, potentially bringing fresh perspectives to the company's leadership. Enhabit operates 256 home health locations and 112 hospice locations across 34 states, leveraging advanced technology to deliver patient care in home settings.